Benefits
Nitric oxide and cardiovascular support
Beet root and red fruit components in reds blends are among the richest dietary sources of inorganic nitrate, which is reduced to nitric oxide (NO) in vivo via the nitrate-nitrite-NO pathway. Elevated NO improves endothelial function, reduces arterial stiffness, lowers blood pressure, and enhances blood flow to working muscles — supporting both cardiovascular health and exercise performance.
Anthocyanin antioxidant and anti-inflammatory activity
Red and purple berries provide high concentrations of anthocyanins — potent flavonoid antioxidants that inhibit NF-κB inflammatory signaling, reduce oxidative LDL cholesterol, and activate endothelial eNOS enzyme for NO production. Tart cherry anthocyanins specifically reduce exercise-induced muscle damage, soreness, and inflammatory markers in clinical studies.
Mitochondrial biogenesis and energy metabolism
Resveratrol-class polyphenols from red grape and berry sources activate SIRT1 deacetylase and downstream PGC-1α — the master regulator of mitochondrial biogenesis. This signaling cascade promotes new mitochondria production, improving cellular energy capacity and metabolic efficiency in muscle, brain, and cardiac tissue.
Mechanism of action
Nitrate-nitrite-NO pathway and eNOS activation
Dietary nitrates from beet root and red vegetables are reduced to nitrite by oral bacteria and further reduced to nitric oxide in hypoxic tissues by xanthine oxidoreductase and deoxyhemoglobin. Simultaneously, anthocyanins and polyphenols activate endothelial NO synthase (eNOS) through PI3K/Akt signaling, providing dual pathways for sustained NO elevation that supports vascular tone, blood pressure, and exercise blood flow.
Clinical trials
Clinical study examining polyphenol-rich reds blend effects on blood pressure, endothelial function (FMD), and antioxidant status. Note: not specifically MitoReds™ trial.
Cardiovascular risk markers.
Reds blend supplementation improved endothelial function (FMD), reduced BP by 3-5 mmHg, improved antioxidant status. CRITICAL CAVEAT: this evidence is for GENERIC red/berry polyphenol blends, not MitoReds™ specifically. MitoReds™-specific peer-reviewed clinical evidence is limited.